Table 3.
|
Underweight U M (SD) | Normal N M (SD) | Overweight Ov M (SD) | Obesity Ob M (SD) | Total M (SD) | df | F | p |
Post hoc
|
|||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
U v N | U v Ov | U v Ob | N v Ov | N v Ob | Ov v Ob | |||||||||
Age (years) |
19.72 (1.71) |
19.83 (1.71) |
20.26 (1.80) |
20.54 (1.97) |
19.91 (1.74) |
3, 3299 |
12.547 |
0.001*** |
|
* |
* |
*** |
* |
|
Physical activity (frequency) |
2.60 (1.14) |
2.87 (1.13) |
2.91 (1.05) |
2.65 (0.94) |
2.86 (1.11) |
3, 3262 |
3.341 |
0.018* |
* |
** |
|
* |
|
|
Diet Quality Index (frequency) |
12.36 (2.22) |
12.24 (2.11) |
12.05 (2.14) |
12.04 (1.89) |
12.21 (2.12) |
3, 3264 |
1.392 |
0.243 |
|
|
|
|
|
|
Overall drug use |
1.53 (0.40) |
1.60 (0.36) |
1.65 (0.36) |
1.72 (0.51) |
1.60 (0.37) |
3, 3226 |
6.961 |
0.001*** |
|
* |
* |
* |
|
|
High-frequency drug use |
2.27 (0.92) |
2.53 (0.88) |
2.65 (0.88) |
2.63 (0.94) |
2.54 (0.88) |
3, 3260 |
6.797 |
0.001*** |
* |
** |
|
* |
|
|
Medium-frequency drug use |
1.27 (0.55) |
1.22 (0.46) |
1.24 (0.47) |
1.45 (0.74) |
1.23 (0.47) |
3, 3267 |
5.293 |
0.001** |
|
|
|
|
** |
* |
Low-frequency drug use | 1.03 (0.12) | 1.04 (0.16) | 1.05 (0.17) | 1.09 (0.35) | 1.04 (0.17) | 3, 3242 | 3.028 | 0.028* | * |
Total sample.
Note: Significance levels for each ANOVA and Scheffé’s post-hoc comparison are depicted by: *p < 0.05, **p < 0.01, ***p < 0.005.